Coherent Market Insights published a business research report on U.S. IV Infusion Products Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. U.S. IV Infusion Products Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4700
The market for IV infusion products is expected to grow substantially in the U.S. in the coming years, driven by an increase in the incidence of chronic diseases. Some of the most common uses for IV infusion products are blood transfusions, chemotherapy, and administration of intravenous fluids and antibiotics. According to the National Health Council, approximately 40 million people in the U.S. suffer from one or more chronic diseases. This market will be driven by these factors.
The U.S. IV infusion products market is expected to record a CAGR of 3.8% during 2021-2028 and was estimated to be valued at US$ 7,885.4 million in 2021. A number of factors are driving the growth of the IV infusion products market, such as the increasing number of blood transfusions. Several companies are entering into partnerships and acquisitions to improve the quality of IV infusion products.
Approval and launch of new products is expected to propel growth of the U.S. IV infusion products market over the forecast period. For example, Innovative Health Sciences, LLC, in July 2021, received CE Mark Certification for Insignis Syringe Infusion System, a combination of intravenous and subcutaneous non-electric infusion pump.
Moreover, high prevalence of chronic diseases is also expected to propel growth of the U.S. IV infusion products market over the forecast period. For instance, according to the Centers of Disease Control and Prevention’s U.S. Cancer Statistics September 2019, around 94,000 women were diagnosed with gynecologic cancer each year, in the U.S., between 2012 and 2016.
Use of IV route and IV infusion products may lead to several complications such as pain in site of injections. Moreover, extravasation of some drugs can cause injury, necrosis, and sloughing of tissues. These side effects are expected to limit growth of the U.S. IV infusion products market.
Major players operating in the U.S. IV infusion products market include, AngioDynamics Inc., AdvaCare Pharma, B. Braun Medical Inc., Becton Dickinson and Company, Cook Group, CODAN Companies, EMED Technologies Corporation, Greiner Bio-One International GmbH, Kimal, Nipro Corporation, PL Medical Co., LLC, Smiths Group plc, Terumo Corporation, Teleflex Inc., and ZOLL Medical Corporation.
By Product Type
- IV Infusion Pump
- Gravity Infusion Devices
- Volumetric Pump
- Syringe Pump
- Infusion Lines (Set)
- Gravity IV Set
- Gravity IV Set W/Needle Free Connector
- Pump IV Set
By Stop Cock Type
- 3 Way Stopcock
- Vacuum Stopcocks
- Burette Stopcocks
By Needle Free Connector
- Standalone Connectors
- Needle-free Extension Sets
By Infusion Site
- Peripheral IV
- Medline IV
- Central IV
- Pain Management
By End User
- Ambulatory Surgical Centers
- Home Care Settings
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4700
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global U.S. IV Infusion Products Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: U.S. IV Infusion Products Industry Impact
Chapter 2 Global U.S. IV Infusion Products Competition by Types, Applications, and Top Regions and Countries
2.1 Global U.S. IV Infusion Products (Volume and Value) by Type
2.3 Global U.S. IV Infusion Products (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global U.S. IV Infusion Products Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America U.S. IV Infusion Products Market Analysis
Chapter 6 East Asia U.S. IV Infusion Products Market Analysis
Chapter 7 Europe U.S. IV Infusion Products Market Analysis
Chapter 8 South Asia U.S. IV Infusion Products Market Analysis
Chapter 9 Southeast Asia U.S. IV Infusion Products Market Analysis
Chapter 10 Middle East U.S. IV Infusion Products Market Analysis
Chapter 11 Africa U.S. IV Infusion Products Market Analysis
Chapter 12 Oceania U.S. IV Infusion Products Market Analysis
Chapter 13 South America U.S. IV Infusion Products Market Analysis
Chapter 14 Company Profiles and Key Figures in U.S. IV Infusion Products Business
Chapter 15 Global U.S. IV Infusion Products Market Forecast (2021-2027)
Chapter 16 Conclusions
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4700
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027